Earn rewards for your opinion on lab products.
Get exclusive insights into life science trends.
Stay up to date on research news.
Latest Tweets
Machine Bio crowned as BioTools Innovator champion
October 15, 2021 -- CARLSBAD, CA - Machine Bio co-founder and CEO David Marash delivered an impassioned pitch that resulted in the protein synthesis company being named the inaugural winner of the BioTools Innovator Competition. Read More
Opportunities abound in cell and gene therapy for discerning investors
October 14, 2021 -- CARLSBAD, CA - There are more opportunities in the cell and gene therapy sector than ever before. But to profit from them, investors must be more discerning than in the past, according to a panel of investors at the Cell & Gene Meeting on the Mesa on October 14. Read More
Precision Advance aims to improve patient access to cell and gene therapy
October 14, 2021 -- Improving patient access to cell and gene therapy treatments is the goal of Precision Advance, an initiative of Precision Medicine Group. Precision Advance provides a set of interconnected services and personnel designed to help bring new therapies to market. Read More
Dialogue with regulators will help bring cell and gene therapies to market
October 13, 2021 -- CARLSBAD, CA - Open engagement and frequent communication with regulators is needed throughout the development process for cell and gene therapies to help bring them to market, according to an October 13 session at the Cell & Gene Meeting on the Mesa. Read More
Catching up with the Alliance for Regenerative Medicine at Cell & Gene Meeting on the Mesa
October 13, 2021 -- CARLSBAD, CA - What's going on at this week's Cell & Gene Meeting on the Mesa? ScienceBoard.net spoke with Stephen Majors, director of public affairs at the Alliance for Regenerative Medicine, who shared what's being discussed at this year's meeting. Read More
What's next for cellular immunotherapies?
October 13, 2021 -- CARLSBAD, CA - What's the next step in the development of cellular immunotherapies, particularly for liquid and solid tumors? At this week's Cell & Gene Meeting on the Mesa, Dr. Kanya Rajangam, PhD, of Nkarta Therapeutics explained the latest approaches. Read More
New algorithm enables comparisons of tumors across patients
October 12, 2021 -- Researchers have developed an algorithm that can take either single-cell mass cytometry data or RNA sequencing data, align it, and extract a common denominator for comparing cancer data among patients. The algorithm, called tuMap, was detailed in a study published on October 7 in Cell Systems. Read More
Tecartus becomes 1st CAR T-cell therapy to receive FDA approval for adults with ALL
October 11, 2021 -- Tecartus (brexucabtagene autoleucel), a CAR T-cell therapy, has gained approval from the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adult patients. Read More
GenSight Biologics to highlight gene therapies at Cell & Gene Meeting
October 11, 2021 -- French biotechnology firm GenSight Biologics is highlighting its lenadogene neparvovec (Lumevoq) and GS030 gene therapies at the Cell & Gene Meeting on the Mesa in Carlsbad, CA. Read More
Scientists create atlas of mouse brain regions down to single cells
October 8, 2021 -- An atlas of the mouse cerebrum and primary motor cortex down to the level of single cells was published in a pair of papers on October 6 in Nature. The research reveals the mammalian brain's organization at an unprecedented level of detail and sheds new light on gene regulatory factors, promising to inform future work on developing targeted therapies for human diseases. Read More
BioTools Innovator announces final 5
October 7, 2021 -- BioTools Innovator has selected five accelerator companies to compete for the title of the first BioTools Innovator program winner. The finalists were selected from a field of over 150 applicants and 10 semifinalists. Read More
Cytek launches new immunoprofiling assay
October 7, 2021 -- Cytek Biosciences has launched a 25-color immunoprofiling assay optimized for its flagship Aurora cell analysis systems. Read More
AI drug development market projected to reach $5.1B by 2025
October 6, 2021 -- The world market for AI applications in drug development is projected to reach $5.1 billion by 2025, an increase of more than $3.6 billion from the market size in 2020. However, significant challenges are lurking ahead as the industry enters the next phase, according to Ulrik Kristensen, PhD, of Emersion Insights. Read More
Scientists tease out role of epithelial cells in lung immunity
October 6, 2021 -- A research group has shown how different lung cell roles guide the immune system, according to a study published online on October 5 in Nature Communications. The findings have larger implications in understanding, preventing, and treating multiple lung pathologies, such as those seen in COVID-19. Read More
Register to attend the BioTools Innovator Capstone Event
October 6, 2021 -- BioTools Innovator is holding its inaugural Capstone Event for the 2021 cohort on Thursday, October 14, at 2 p.m. PST, 5 p.m. EST. The event is co-located with the Cell & Gene Therapy Meeting on the Mesa in Carlsbad, CA. Read More
Science In Brief
BioTools Innovator
Conferences
Interphex 2021
October 19-21
New York City, New York United States
October 19-21
New York City, New York United States
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
November 10-14
Washington, DC, District of Columbia United States
Connect
Latest Tweets